A1C928 AF NFT

Topoisomerase 1-associated factor 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifer5hw5eppxhppxbph6nmrwm4vpr6rnlxtz6emtnzkqahn6lzdbi/metadata.json
IPFS of structure file: 
bafybeid6dvt7byrk6fytynetfdwdmpehhfnzxg7yjerpnpw2tmcua3ezui/AF-A1C928-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5BeA89782341f98147F2D811B063F91F0aE7D7bF
First NFT owner address (bech32): 
genesis1t04gj7prg8ucz3ljmqgmqcleru9w04al6k7v50
Current NFT ID #469419 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
469419
Accession (UniProt):
A1C928
Name::
Topoisomerase 1-associated factor 1
Experimental Method:
Predicted structure
Sequence source:
Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A1C928 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A1C928|TOF1_ASPCL Topoisomerase 1-associated factor 1 OS=Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107) OX=344612 GN=tof1 PE=3 SV=1 MDDEGAPLSESAQVVDPDVRAHVYSLVTALGGFNGENADRYVLGDDALACLRDIKRWLKLHDEKNNRMDVARCLGEANLVNGDLLPILTLWSTSGQNSKFMSRIALACLELLVPLTWPLELHSEMTVNHHRHTPYLQQAQVLYKRGILGPGGSSLLRTIIRIGLPSMAVPRSDRTTRDEGILKLMLYLLRNIAVISPHSRLSAEGDEEETSRSATINAFQDQDAFALLLTMCSNVADDFNLQDVVLLEILFHIVKGVNVEKLFMNDTQRKAKRTEELGDLLQKESSLRREYAKNAPTRHGRFGTMIWVKRDDAKVSTVSGQDVLKDSQTTLYKMDQSKKWNKPQVRRRQTEVTVNNDFNTPVNLNSTATKNLRIFIEEFLDSGFNPLFTHVRKAIEREADRIMDINSRHYFYTVAWFLEAERVRRKYQRERHSQEDKSLKKMEPDSFALVASVLNQETFVFLNRSMQKSFDNKEVEDLTAEMRCFTQILLTVQEMAQSPLDDDQEVADNIQNRIFYEETTHDRIISIIRGYKDQGFGYLDACTQLAHVFLRMLEHYSKENVDMQIRSRRRIKRKAKQDDQAIDVEDEEHASEDEELMEAERVSKERKFDFKRFAAKFCNQKCVDTFVAFIKYYKELNTDQLKRAHRYFYRIAFKQEMSVLLFRLDIINLFYRMIKGPGALDSSKPIFKEWEELVRQILRRMIKKIDQRPALITELLFSKINSTVFYLEFGFEKQTISVSKRPPAELEVDPREAKTTDEKLSIVVRVMIKDEHINLVKWISEVLRLAADERESWESREQQPGEPTAPNPMIPVKPDDEACQKAMFSNAKLRLLMTLIGFERLGMEDVPGASWVVPSSFTSDDLRHTKRVIDQCLIEPATEDPDQDLSRLIRRKYANDARGGGRDEQNLDIDFGSDSEGEDNVPDGPLFPPNHRSKANALDQLKKQRQKRRKEDGDRETPDDEVLEERRRARLENALARQAKIKSDLYIHASDEESDEEADEEFFRLEEQRRKEQAARIKHALLHGVVEEISDKSSKKTGRKRQSDQHTTLNIDAHTKRQRRKNRTDKLDEGDDLVMAGTEAQSPDSPGLGSSSHDAKGIENTPLTSDEDELEFDDDLAFSRDRNRRKDFTPNVDKMVIEPAQQDADPAAPDEDDDEDAPVVGSSRRRVRGGFVIESDSE